ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

Manylion Llyfryddiaeth
Prif Awduron:	Burton, A, Martin, R, Holly, J, Hamdy, F, Neal, D, Donovan, J, Tilling, K
Fformat:	Journal article
Cyhoeddwyd:	2011

Eitemau Tebyg

Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring.
gan: Burton, A, et al.
Cyhoeddwyd: (2012)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
gan: Burton, A, et al.
Cyhoeddwyd: (2013)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
gan: Tilling, K, et al.
Cyhoeddwyd: (2010)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
gan: Harrison, S, et al.
Cyhoeddwyd: (2016)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
gan: Catto, J, et al.
Cyhoeddwyd: (2011)

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
gan: Catto, J, et al.
Cyhoeddwyd: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
gan: Young, GJ, et al.
Cyhoeddwyd: (2017)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
gan: Roddam, A, et al.
Cyhoeddwyd: (2005)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
gan: Collin, S, et al.
Cyhoeddwyd: (2009)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
gan: Wade, J, et al.
Cyhoeddwyd: (2015)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
gan: Lane, J, et al.
Cyhoeddwyd: (2009)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
gan: Hamdy, F, et al.
Cyhoeddwyd: (2006)

Metabolic imbalance and prostate cancer progression.
gan: Burton, A, et al.
Cyhoeddwyd: (2010)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
gan: Törnblom, M, et al.
Cyhoeddwyd: (2001)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
gan: Ulrika Rönningås, et al.
Cyhoeddwyd: (2019-07-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
gan: Sävblom, C, et al.
Cyhoeddwyd: (2009)

Prostate Specific Antigen (PSA): The Historical Perspective
gan: T. Ming Chu
Cyhoeddwyd: (2020-12-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
gan: Amit M. Algotar PhD, MBBS, et al.
Cyhoeddwyd: (2011-05-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
gan: Lane, J, et al.
Cyhoeddwyd: (2004)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
gan: , DAHESIHDEWI, Andaru, et al.
Cyhoeddwyd: (2002)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
gan: Priya Duvedi, et al.
Cyhoeddwyd: (2019-05-01)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
gan: Avery, K, et al.
Cyhoeddwyd: (2007)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
gan: Littlejohns, T, et al.
Cyhoeddwyd: (2016)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
gan: Jin-Woo Jung, et al.
Cyhoeddwyd: (2019-01-01)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
gan: Oliver, SE, et al.
Cyhoeddwyd: (2004)

PSA testing for men at average risk of prostate cancer
gan: Bruce K Armstrong, et al.
Cyhoeddwyd: (2017-07-01)

Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
gan: Andrew J Simpkin, et al.
Cyhoeddwyd: (2015-07-01)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
gan: Zuccolo, L, et al.
Cyhoeddwyd: (2013)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
gan: Lane, J, et al.
Cyhoeddwyd: (2007)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
gan: Harrison, S, et al.
Cyhoeddwyd: (2020)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
gan: Oliver, SE, et al.
Cyhoeddwyd: (2004)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
gan: Simpkin, A, et al.
Cyhoeddwyd: (2013)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
gan: Avery, K, et al.
Cyhoeddwyd: (2008)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
gan: Blijenberg, BG, et al.
Cyhoeddwyd: (2003)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
gan: Down, L, et al.
Cyhoeddwyd: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
gan: Down, L, et al.
Cyhoeddwyd: (2011)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
gan: Hamdy, FC, et al.
Cyhoeddwyd: (2020)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
gan: Rosario, D, et al.
Cyhoeddwyd: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
gan: Rosario, D, et al.
Cyhoeddwyd: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
gan: Rosario, D, et al.
Cyhoeddwyd: (2012)